Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCSA0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,980
Award facts
- Contract value 100% obligated
- $13,979.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for Xolair 300 mg/2 ml autoinjector supply with a ceiling value of $13,979.52, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. Ultimate completion date is March 10, 2026. The order is priced firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FCSA0?
SPE2DR26FCSA0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 17, 2026.
How much is contract SPE2DR26FCSA0 worth?
The government has obligated $13,980 on SPE2DR26FCSA0.
Is contract SPE2DR26FCSA0 an order under another contract?
Yes. SPE2DR26FCSA0 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCSA0 competed?
The extent of competition for SPE2DR26FCSA0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award